No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subiects

Türk J Gastroenterol (ISI),Cilt 25,639- 43pp, 2014 Yonal O, Eren F, Yılmaz Y, Atuğ Ö, Över HEL

Noninvasive assessment of liver fıbrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver liver disease.

Hepatitis Monthlv (ISIT Cilt 11, 103-6 pp.,2011 Yilmaz Y, Yonal O, Kurt R, Bayrak M, Aktas B, Ozdogan O

Primary malignant melanoma of the esophagus.

Case Reports in Gastroenterology (ISI), Cilt 7, 272-6 pp., 2013 Yonal O, ibrişim D, Songur Y, Cakaloglu Y, Tuncer K, Kirimlioglu H, Ozdil S.

Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis

Açta Gastroenterologica Belgica (ISI). Cilt 75,240-4 pp.,2012 Yilmaz Y, Yonal O, Deyneli O, Celikel CA, Kalayci C, Duman DG.

Should maintenance therapy be performed in ulcerative proctitis? How long should it be continued?

Turkish Journal of Gas t roentero 1 ogy (ISf f Ci 11 23, 21-4 pp., 2012 Yönal O, Hatemi G, Kaymakoğlu S.

Do anti-TNF agents and combination treatment increase pöstoperative complication risk?

Turkish Journal of GastroenterologyflSD. Cilt 23, 25-9 pp., 2012 Yönal O, Hatemi G, Hamzaoğlu Ö.

Serum galectin-3 levels in patients with nonalcoholic fatty liver disease

Clinical Biochemistry (ISI), Cilt 44, 955-8 pp.,2011 Yilmaz Y, Eren F, Kurt R, Yonal O, Polat Z, Senates E, Bacha M, Imeryuz N

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity

Journal of Crohn?s and Colitis aSF). Cilt 5,402-6 pp.,2011 Yilmaz Y, Yonal O, Eren F, Atug O, Över Hamzaoglu H

Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease

Atherosclerosis(ISI), Cilt 217,125-9 pp.,2011 Yilmaz Y, Kurt R, Gurdal A, Alahdab YO, Yonal O, Senates E, Polat N, Eren F, Imeryuz N, Oflaz H.

Serum progranulin as an independent marker of liver fıbrosis in patients with biopsy-proven nonalcoholic fatty liver disease

Disease Markers (ISI), Cilt 31, 205-10 pp., 2011 Yilmaz Y, Eren F, Yonal O, Polat Z, Bacha M, Kurt R, Ozturk O, Avsar E.